OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2022
(3)
2021
(3)
2020
(1)
2019
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Psychological Impact of
TP53
-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort.
Not available
S-EPMC9221115
|
biostudies-literature
Cite
Determinants of COVID-19 Vaccine Hesitancy in Portuguese-Speaking Countries: A Structural Equations Modeling Approach.
Not available
S-EPMC8541102
|
biostudies-literature
Cite
Checklists for Assessing Skills of Children With Type 1 Diabetes on Insulin Injection Technique.
Not available
S-EPMC9294572
|
biostudies-literature
Cite
The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus.
Not available
S-EPMC6743794
|
biostudies-literature
Cite
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
Not available
S-EPMC9539129
|
biostudies-literature
Cite
Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward.
Not available
S-EPMC8656743
|
biostudies-literature
Cite
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
Not available
S-EPMC7397242
|
biostudies-literature
Cite
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
Not available
S-EPMC5710484
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets